KOMIPHARM INTERNATIONAL CO., LTD.
Founded in 1972 and listed on KOSDAQ in 2001, Komipharm develops veterinary vaccines and the human anticancer drug PAX-1, including an African swine fever vaccine.
Price
Change
Market cap
Products & technology
- PAX-1 (Comenox)Anticancer, cancer-pain, and antiviral treatment
- Pro-vac PED-FcPorcine epidemic diarrhea vaccine
Regulatory approvals
data.go.kr1 Korean MFDS drug approvals · 2017
- MFDS drug코미아스피린정(수출용)2017-04-27Drug · OTC · Notification201702179
Clinical trials
data.go.kr2 MFDS clinical trial authorisations · 2012–2022 (Phase 2 2)
- Phase 2Panaphix(PAX-1)2022-11-01
3 trial sites
- Phase 2KOMINOX2012-12-28
2 trial sites
R&D and key agreements
Source: DART corporate disclosurePAX-1 교모세포종 · 교모세포종(뇌암) · 임상2상 완료(호주·한국), 2b상 확대임상 준비중 · Completed Phase 2 glioblastoma trials in Australia and Korea and is preparing an expanded Phase 2b trial with more participants.
PAX-1 말기암 통증치료 · 말기암 환자 마약성진통제 저감·대체 · 임상2상 완료(대만·엘살바도르), 다국가 2b상 인허가심사중 · Completed Phase 2 trials in Taiwan and El Salvador and is analyzing results; an open-label Phase 2 trial in hospice patients is under way in El Salvador, and a multinational Phase 2b trial with an extended 8-week dosing period is under regulatory review.
PAX-1 뇌전이암 · 뇌전이암 · 미국 FDA 임상1/2상 승인, 개시준비중 · Received FDA approval for a Phase 1/2 trial for brain-metastasis treatment in the US and is preparing to begin it.
ASF 약독화 생백신 · 아프리카돼지열병(ASF) · 필리핀 야외임상시험 진행중(2026년 7월 종료 목표) · Developed both an injectable and an oral (bait) vaccine in collaboration with Korea's Animal and Plant Quarantine Agency, the National Wildlife Disease Control Institute, and Chonbuk National University's Institute of Zoonotic Disease Research; 13 domestic laboratory trials met all safety criteria. Related research was published in Animals (MDPI) in January 2025 and in Transboundary and Emerging Diseases (Wiley) in July 2025.
AI reads
MAA server logs · IP-verifiedSomeone asked an AI a question, and it fetched this page live to answer.
Collected for later use. Not a signal of interest.
- OpenAIChatGPT-Useranswer4
- OpenAIOAI-SearchBot2
- PerplexityPerplexityBot1
Measured since Aug 25, 2026 · 2 AI engines · last read Aug 26, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition